ADVB Stock Price, Chart, Stats & News

Advanced Biomed Inc. Common Stock
Save
Advanced Biomed Inc. Common Stock (ADVB) does not currently pay a dividend.
10.75M
Market cap
–
Current P/E
–
Forward P/E
ADVB chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | 46.67% |
ROE | 100.82% |
D/E | 0.00x |
Interest coverage ratio | – |
ADVB valuation
P/E | – |
P/S | – |
P/B | 9.55x |
P/CF | -25.83x |
P/FCF | -1.29x |
P/OCF | -25.83x |
PEG | 0.08x |
EV multiple | -5.00x |
About
Advanced Biomed Inc. functions as an investment holding company, primarily dedicated to the research and development of microfluidic biochip technologies. Based in Taiwan, the company leverages these innovations to enhance precision oncology, spanning cancer detection, diagnosis, and treatment. Its diverse product portfolio includes a suite of advanced devices: A+Pre: A fully automated system designed for pre-concentrating diluted blood samples.
Similar securities
Based on sector and market capitalization
Report issue





